Walleye Trading’s Nuvation Bio NUVB Stock Holding History

Walleye Trading’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-15,462	Closed	-$154K	–	5695
2021 Q3	$154K	Buy	+15,462	New	+$140K	﹤0.01%	4094

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Walleye Trading's NUVB Position: Q4 2021 in Review

Walleye Trading sold out of Nuvation Bio (NUVB) in Q4 2021, closing a stake of 15,462 shares — an estimated $154K sold.

Walleye Trading first reported a position in NUVB in Q3 2021 and held it in 1 quarter. The position peaked at $154K in Q3 2021. 105 funds tracked by Wall St. Rank hold NUVB as of Q4 2021.

Walleye Trading reported no remaining Nuvation Bio position as of Q4 2021 after selling out during the quarter.
Walleye Trading sold 15,462 Nuvation Bio shares in Q4 2021, an estimated $154K.
Walleye Trading first reported a position in Nuvation Bio in Q3 2021 and held it in 1 quarter.
Walleye Trading's Nuvation Bio position peaked at $154K in Q3 2021.
105 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2021.

Based on Walleye Trading's 13F filing for Q4 2021, filed 14 Feb 2022.